BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15363936)

  • 1. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A; Dutta GP; Bhakuni V; Tripathi R
    Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
    Tripathi R; Pandey SK; Rizvi A
    Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
    Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS
    In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
    Singh C; Malik H; Puri SK
    J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy.
    Ahmad R; Srivastava AK
    Parasitology; 2007 Jul; 134(Pt 7):931-8. PubMed ID: 17352848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
    Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
    Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
    Neerja J; Puri SK
    Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of Plasmodium yoelii nigeriensis resistant to triple drug combination (sulphadoxine/pyrimethamine/mefloquine) and its response to other antimalarials.
    Shukla B; Bajpai R; Dutta GP
    Indian J Malariol; 1988 Jun; 25(1):1-6. PubMed ID: 3266603
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active 1,2,4-trioxepanes: synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice.
    Singh C; Pandey S; Sharma M; Puri SK
    Bioorg Med Chem; 2008 Feb; 16(4):1816-21. PubMed ID: 18054238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice.
    Kimbi HK; Fagbenro-Beyioku AF; Oyibo WA
    Indian J Malariol; 1998 Mar; 35(1):35-8. PubMed ID: 10319560
    [No Abstract]   [Full Text] [Related]  

  • 14. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B; Dutta GP
    J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
    Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
    Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):634-5. PubMed ID: 8997840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
    Singh C; Kanchan R; Sharma U; Puri SK
    J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors.
    Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K
    Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial interaction of quinine and quinidine with clarithromycin.
    Pandey SK; Dwivedi H; Singh S; Siddiqui WA; Tripathi R
    Parasitology; 2013 Mar; 140(3):406-13. PubMed ID: 23137860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.